HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Abstract
We describe a successful program of poliomyelitis control using a combination of killed and live polio vaccines over a 10-year period in two developing areas, the West Bank and Gaza, adjacent to a relatively developed country, Israel. During the 1970s, immunization using live trivalent oral polio vaccine (OPV) in these areas covered more than 90 percent of the infant population. Nevertheless, the incidence of paralytic polio continued to be high, with many cases occurring in fully or partially immunized persons. It was thought that this could be due to interference with OPV take by other enteroviruses present in the environment due to poor sanitary conditions in these areas. A new policy combining five doses of OPV with two doses of inactivated polio vaccine (IPV) was adopted and implemented in 1978. In the 10 years since then, immunization coverage of infants increased to an estimated 95 percent and paralytic poliomyelitis has been controlled, despite exposure to wild poliovirus from neighboring countries including an outbreak in Israel in 1988. This experience suggests that wide coverage using the combination of IPV and OPV is an effective vaccination policy that may make eradication of polio possible even in developing areas.
AuthorsT Tulchinsky, Y Abed, S Shaheen, N Toubassi, Y Sever, M Schoenbaum, R Handsher
JournalAmerican journal of public health (Am J Public Health) Vol. 79 Issue 12 Pg. 1648-52 (Dec 1989) ISSN: 0090-0036 [Print] United States
PMID2817193 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Poliovirus Vaccine, Inactivated
  • Poliovirus Vaccine, Oral
Topics
  • Disease Outbreaks
  • Health Policy
  • Humans
  • Incidence
  • Infant
  • Israel (epidemiology)
  • Poliomyelitis (epidemiology, prevention & control)
  • Poliovirus Vaccine, Inactivated (therapeutic use)
  • Poliovirus Vaccine, Oral (therapeutic use)
  • Seroepidemiologic Studies
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: